| ConVerge combines a
unique, regional approach to laboratory
testing with innovative technology
to offer you reliable results. When
you use ConVerge as your laboratory
resource, you benefit from each of
our business units, which are specially
designed to meet your needs and the
needs of the medical laboratory industry.
CytoDx™
continues to grow as one of the
largest regional anatomic pathology
laboratories in New England, providing
diagnostic and technical services
to over 225,000 patients annually.
We provide tissue and cytology processing
to community hospitals and pathologists,
as well as comprehensive anatomic
pathology services to independent
healthcare practitioners. HybriDx™ previously
known as Laboratory for Clinical
Medicine (LCM), is our clinical
laboratory that has been renamed
HybriDx Integrated Diagnostics to
emphasize the expanding role of
molecular diagnostics in bridging
anatomic and clinical pathology.
FMDx™ is designed
to introduce Flow Cytometry and Molecular
Diagnostics in the laboratory testing
process. We partner with hospitals and
independent laboratories to help them
bring these exciting but complex disciplines
to their organizations.
CRDx™ (Contract
Research & Development), our contract
research organization, was created to
assist in-vitro diagnostic (IVD) vendors
with method design and validation. Through
these partnerships, we enhance our ability
to introduce cutting edge technologies
in CytoDx and HybriDx, as well as service
our FMDx clients.
|
